Advisory Resource Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $1.4M | Buy |
|
|||||
|
2025
Q3 | $1.25M | Buy |
|
|||||
|
2025
Q2 | $1.05M | Buy |
|
|||||
|
2025
Q1 | $1.01M | Buy |
|
|||||
|
2024
Q4 | $1.03M | Buy |
|
|||||
|
2024
Q3 | $886K | Sell |
|
|||||
|
2024
Q2 | $1.07M | Buy |
|
|||||
|
2024
Q1 | $940K | Buy |
|
|||||
|
2023
Q4 | $672K | Sell |
|
|||||
|
2023
Q3 | $635K | Buy |
|
|||||
|
2023
Q2 | $563K | Sell |
|
|||||
|
2023
Q1 | $605K | Sell |
|
|||||
|
2022
Q4 | $560K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $240K | Sell |
|
|||||
|
2022
Q1 | $288K | Buy |
|
|||||
|
2021
Q4 | $239K | Buy |
|
|||||
|
2021
Q3 | $202K | Sell |
|
|||||
|
2021
Q2 | $201K | Buy |
|